Growth Potential of Specific Biomarker-Based Tests: White Paper

   Single User - $0

Published Feb 9, 2016 | 3 Pages | Pub ID: KLI5878138

This White Paper, Growth Potential for Specific Biomarker-Based Tests discusses the market environment for tests involving a biomarker.  Markers are "scored" according to their revenue growth potential compared to each other.  A market and forecast for all tests are provided, as well as a list of companies that are involved in the market.  Markers discussed include: CEA, HIV Rapid Marker-Based, AFP, FOB, Rapid PSA, NMP22, Cardiac Markers-Acute, C difficile Marker-Based, hsCRP, HIV Marker-Based, STD Marker-Based, proBNP, PT/INR, Malaria Markers, Thyroid Marker-Based, PSA, CA125, HbA1c.  For specific dollar figures and growth rates, Kalorama's full-length study on Biomarker Markets should be consulted.  
  • Overview
  • Specific Marker-Based Tests Revenue Growth Score
  • Companies in the Market
  • About the Report

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.